top of page
company_01.png

DESIGN & DEVELOPMENT OF NOVEL DRUGS BASED ON A NEW TECHNOLOGY

QBR A/S

PIONEERING SOLUTIONS TO
THE GREATEST THREATS IN MODERN MEDICINE

THERE IS AN URGENT
NEED TO COMBAT VIRAL
INFECTIONS THAT CAN
CAUSE PANDEMICS.


 

​

THE WORLD IS HEADING
TO A POST-ANTIBIOTIC
ERA IN WHICH COMMON
INFECTIONS COULD ONCE
AGAIN KILL (WHO)

​

company_02.png

QBR A/S is a Danish company developing novel Anti Microbial & Anti Viral Peptides as a new class of drugs in infectious diseases.

QBR is at the forefront of the interface of Physics and Chemistry in drug design, utilizing a ground- breaking Resonant Recognition Model – RRM.

company_03.png

PARTNERSHIPS & IP​

  • AMALNA Consulting (AU), RRM Technology.

  • Loma Linda University Hospital (USA), collaborative reresearch and testing facilities.

  • Ljubljana University (SLO) collaborative research and Lab level 3 testing facilities.

  • Pepscan (NL), collaboration agreement regarding development of GMP grade of Peptide Cov18A.

  • Leukocare (D), development of non-toxic solvents.

  • QBR has cooperation agreement with all parties and is the owner of the patented IP.

QBR Team

IVAN

LONCAREVIC

​

CEO

​

Physics,
Copenhagen University

​

More then 20 years experience as an entrepreneur and as consultant for private sector and universities, developing Innovative companies and research project in bio- physical systems.
 

PROF. IRENA
COSIC

​

RRM TECHNOLOGY

​

AMALNA Consulting
Australia


Director and founder of AMALNA consulting. Development of RRM model since 1994. Experience in biophysics, biomedical engineering and biomedical signal processing.

PROF. UROS
KRAPEZ

​

VIROLOGY

​

Ljubljana University
Slovenia

​

25 years research in respiratory viral infections, herpesviruses, avian pathogenics, Covid19 virus, more then 105 scientific papers published regarding viral infections.
 

PROF. HANSEL FLETCHER

​

RESISTANT BACTERIA

​

Loma Linda University Hospital, USA.

​

Assistant Dean;
M
icrobiology Division; Pharmaceutical Science, molecular genetics and biochemistry of microbial diseases, his research program has been focused on bacterial pathogens and recently resistant bacteria.
 

PROF. ALEN ALBRETH

​

BIO-CHEMISTRY

​

National Institute of
Chemistry, Slovenia

​

Specialising in  liquid chromatography
spe
ctrometry,  mass spectrometry, complex biological bio fluids,
analytical method development.
....

 

bottom of page